!
!
Sign in / Join ICS
Home
Efficacy and Safety of Fesoterodine for Overactive Bladder in a Double-Blind, Head-to-Head Comparison Trial With Tolterodine ER and Placebo
Herschorn S
1
, Swift S
2
, Guan Z
3
, Carlsson M
3
, Brodsky M
3
, Gong J
3
Abstract Category
Pharmacology: Clinical
Abstract 710
Read by Title
Scientific Non Discussion Abstract Session 34
1.
University of Toronto, Toronto, ON, Canada,
2.
Medical University of South Carolina, Charleston, SC, USA,
3.
Pfizer Inc, New York, NY, USA
Links
Abstract PDF
Edit Abstract
Abstract Centre
Abstract
28/03/2024 05:32:34